Growth Metrics

ProQR Therapeutics (PRQR) Shares Outstanding (2017 - 2025)

ProQR Therapeutics' Shares Outstanding history spans 6 years, with the latest figure at $122.6 million for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 9.09% to $122.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $122.6 million, a 9.09% increase, with the full-year FY2025 number at $122.6 million, up 9.09% from a year prior.
  • Shares Outstanding hit $122.6 million in Q4 2025 for ProQR Therapeutics, up from $112.4 million in the prior quarter.
  • Over the last five years, Shares Outstanding for PRQR hit a ceiling of $122.6 million in Q4 2025 and a floor of $81.6 million in Q4 2021.
  • Historically, Shares Outstanding has averaged $97.3 million across 5 years, with a median of $87.5 million in 2023.
  • Biggest five-year swings in Shares Outstanding: increased 1.1% in 2022 and later increased 28.44% in 2024.
  • Tracing PRQR's Shares Outstanding over 5 years: stood at $81.6 million in 2021, then increased by 1.1% to $82.5 million in 2022, then rose by 6.16% to $87.5 million in 2023, then grew by 28.44% to $112.4 million in 2024, then rose by 9.09% to $122.6 million in 2025.
  • Business Quant data shows Shares Outstanding for PRQR at $122.6 million in Q4 2025, $112.4 million in Q4 2024, and $87.5 million in Q4 2023.